Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | BCHE | P06276 | 2/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | CTSK | P43235 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18605401 | 0.90 | ALDH1A1 (0.44) | ALDH1A1BCHE | |
| SCHEMBL31756156 | 0.87 | ALDH1A1 (0.41) | ALDH1A1BCHEAGTR2EPHX2 | |
| SCHEMBL8462145 | 0.84 | ALDH1A1 (0.44) | ALDH1A1BCHEKDM4E | |
| SCHEMBL20363383 | 0.84 | ALDH1A1 (0.38) | ALDH1A1BCHE | |
| SCHEMBL18582000 | 0.84 | ALDH1A1 (0.38) | ALDH1A1BCHE | |
| SCHEMBL18582001 | 0.84 | ALDH1A1 (0.38) | ALDH1A1BCHE | |
| SCHEMBL12017809 | 0.81 | ALDH1A1 (0.49) | ALDH1A1CTSLCTSBCTSKAGTR2 | |
| SCHEMBL6671627 | 0.79 | BCHE (0.49) | ALDH1A1BCHE | |
| SCHEMBL52862 | 0.79 | ALDH1A1 (0.44) | ALDH1A1BCHECTSLCTSBCTSK | |
| SCHEMBL22965651 | 0.78 | BCHE (0.48) | ALDH1A1BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5912247-A | BLOOD FLOW INHIBITION; SIDE EFFECT REDUCTION | KANEBO, LTD. (JP) | 1999-06-15 | — | — | US | disclosed |
| EP-0743308-A2 | Quinazoline compound and anti-tumor agent containing said compound as an active ingredient | KANEBO, LTD. (JP) | 1996-11-20 | — | — | EP | disclosed |